<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="149853-2018" EDITION="2018067"><TECHNICAL_SECTION><RECEPTION_ID>18-152134-001</RECEPTION_ID><DELETION_DATE>20180515</DELETION_DATE><FORM_LG_LIST>RO </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>67</NO_OJ><DATE_PUB>20180406</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 067-149853</NO_DOC_OJS><URI_LIST><URI_DOC LG="RO">http://ted.europa.eu/udl?uri=TED:NOTICE:149853-2018:TEXT:RO:HTML</URI_DOC></URI_LIST><LG_ORIG>RO</LG_ORIG><ISO_COUNTRY VALUE="RO"/><IA_URL_GENERAL/><ORIGINAL_CPV CODE="33652000">Antineoplastic and immunomodulating agents</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="RO124">Harghita</n2016:PERFORMANCE_NUTS><VALUES_LIST><VALUES TYPE="GLOBAL"><RANGE_VALUE><VALUE CURRENCY="RON">1 638 613,92</VALUE><VALUE CURRENCY="RON">15 525 220,80</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="GLOBAL"><RANGE_VALUE><VALUE CURRENCY="RON">1 638 613,92</VALUE><VALUE CURRENCY="RON">15 525 220,80</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">10 567,20</VALUE><VALUE CURRENCY="RON">42 268,80</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">3 907,20</VALUE><VALUE CURRENCY="RON">15 628,80</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">12 931,20</VALUE><VALUE CURRENCY="RON">51 724,80</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">31 024,80</VALUE><VALUE CURRENCY="RON">124 099,20</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">85 056,00</VALUE><VALUE CURRENCY="RON">340 224,00</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">122 371,20</VALUE><VALUE CURRENCY="RON">1 223 712,00</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">303 768,00</VALUE><VALUE CURRENCY="RON">3 037 680,00</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">330 750,24</VALUE><VALUE CURRENCY="RON">3 307 502,40</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">528 336,48</VALUE><VALUE CURRENCY="RON">5 283 364,80</VALUE></RANGE_VALUE></VALUES><VALUES TYPE="PER_LOT"><RANGE_VALUE><VALUE CURRENCY="RON">209 901,60</VALUE><VALUE CURRENCY="RON">2 099 016,00</VALUE></RANGE_VALUE></VALUES></VALUES_LIST></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180404</DS_DATE_DISPATCH><DD_DATE_REQUEST_DOCUMENT>20180504 15:00</DD_DATE_REQUEST_DOCUMENT><DT_DATE_FOR_SUBMISSION>20180515 16:00</DT_DATE_FOR_SUBMISSION><AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="3">Submission for one or more lots</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01202</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Pyмъния</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Антинеопластични средства и имуномодулатори</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Rumunsko</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastika a imunomodulátory</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Rumænien</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastiske og immunmodulerende midler</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Rumänien</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastische und immunmodulierende Mittel</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ρουμανία</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Romania</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastic and immunomodulating agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Rumanía</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Agentes antineoplásicos e inmunomoduladores</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Rumeenia</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastilised ja immuunmoduleerivad ained</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Romania</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Solunsalpaajat ja sytostaatit sekä immunomodulantit</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Roumanie</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antinéoplasiques et immunomodulateurs</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Rómáin, an</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastic and immunomodulating agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Rumunjska</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastični lijekovi i imunomodulatori</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Románia</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Daganatellenes és immunmodulátor szerek</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Romania</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Agenti antineoplastici e immunomodulatori</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Rumunija</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antinavikiniai vaistai ir imunomoduliatoriai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Rumānija</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastiskie līdzekļi un imūnmodulatori</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>ir-Rumanija</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Aġenti ta' l-antineoplastika u ta' l-immunomodulaturi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Roemenië</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastische en immunomodulerende middelen</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Rumunia</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Środki przeciwnowotworowe i immunomodulacyjne</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Roménia</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplásicos e imunomoduladores</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>România</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplazice şi imunomodulatoare</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Rumunsko</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Antineoplastické a imunomodulačné činidlá</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Romunija</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Zdravila z delovanjem na novotvorbe in imunomodulatorji</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Rumänien</TI_CY><TI_TOWN>Miercurea Ciuc</TI_TOWN><TI_TEXT>Cytostatika/cytotoxiska medel och immunmodulerande medel</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="RO">Spitalul Județean de Urgență Miercurea Ciuc</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT CATEGORY="ORIGINAL" FORM="2" LG="RO" VERSION="R2.0.8.S03.E01"><FD_CONTRACT CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION><NAME_ADDRESSES_CONTACT_CONTRACT><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Spitalul Județean de Urgență Miercurea Ciuc</OFFICIALNAME></ORGANISATION><ADDRESS>Str. Dr. Deneș Laszlo nr. 2</ADDRESS><TOWN>Miercurea Ciuc</TOWN><POSTAL_CODE>530180</POSTAL_CODE><COUNTRY VALUE="RO"/><CONTACT_POINT>Molnar Ildiko</CONTACT_POINT><PHONE>+40 372661265</PHONE><E_MAILS><E_MAIL>achizitiipubl@spitalmciuc.ro</E_MAIL></E_MAILS><FAX>+40 266372137</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT><URL_BUYER>www1.e-licitatie.ro</URL_BUYER></INTERNET_ADDRESSES_CONTRACT><FURTHER_INFORMATION><IDEM/></FURTHER_INFORMATION><SPECIFICATIONS_AND_ADDITIONAL_DOCUMENTS><IDEM/></SPECIFICATIONS_AND_ADDITIONAL_DOCUMENTS><TENDERS_REQUESTS_APPLICATIONS_MUST_BE_SENT_TO><IDEM/></TENDERS_REQUESTS_APPLICATIONS_MUST_BE_SENT_TO></NAME_ADDRESSES_CONTACT_CONTRACT><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY_OTHER VALUE="OTHER">Spitalul Județean de Urgență</TYPE_OF_CONTRACTING_AUTHORITY_OTHER><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_NO/></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION><OBJECT_CONTRACT_INFORMATION><DESCRIPTION_CONTRACT_INFORMATION><TITLE_CONTRACT><P>Medicamente oncologice II</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION><TYPE_CONTRACT VALUE="SUPPLIES"/><TYPE_SUPPLIES_CONTRACT VALUE="PURCHASE"/></TYPE_CONTRACT_LOCATION><LOCATION_NUTS><LOCATION><P>Miercurea Ciuc, Str. Denes Laszlo nr. 2, farmacia spitalului.</P></LOCATION><n2016:NUTS CODE="RO124"/></LOCATION_NUTS><NOTICE_INVOLVES><ESTABLISHMENT_FRAMEWORK_AGREEMENT/></NOTICE_INVOLVES><F02_FRAMEWORK><SEVERAL_OPERATORS><MAX_NUMBER_PARTICIPANTS>5</MAX_NUMBER_PARTICIPANTS></SEVERAL_OPERATORS><DURATION_FRAMEWORK_MONTH>48</DURATION_FRAMEWORK_MONTH><TOTAL_ESTIMATED><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="1638613.92">1 638 613,92</LOW_VALUE><HIGH_VALUE FMTVAL="15525220.80">15 525 220,80</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY><FREQUENCY_AWARDED_CONTRACTS><P>Frecventa CS este lunara, trimestriala, semestriala, anuala sau ori de cate ori este necesar, in functie de bugetul alocat.</P><P>AC: Pentru fiecare lot in parte, cant. estimata min. si cant. estimata max. – in conformitate cu prevederile caietului de sarcini si Anexa B.</P><P>CS: Pentru fiecare lot in parte, cant. estimata min. si cant. estimata max. – in conformitate cu prevederile caietului de sarcini si Anexa B.</P><P>Cel mai mare CS: Cantitatea maxima si valoarea estimata maxima – in conformitate cu prevederile caietului de sarcini si Anexa B.</P></FREQUENCY_AWARDED_CONTRACTS></TOTAL_ESTIMATED></F02_FRAMEWORK><SHORT_CONTRACT_DESCRIPTION><P>Autoritatea contractanta doreste sa achizitioneze medicamente in conformitate cu prevederile din caietul de sarcini. Produsele mentionate la loturile 6, 7, 8, 9 si 10 sunt medicamente care fac obiectul contractului Cost-volum si Cost-volum rezultat, publicat de CNAS.</P><P>Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificari sau informatiilor suplimentare in a 10-a zi inainte de data limita de depunere a ofertelor.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><CONTRACT_COVERED_GPA VALUE="NO"/><F02_DIVISION_INTO_LOTS><F02_DIV_INTO_LOT_YES VALUE="ONE_OR_MORE_LOT"><F02_ANNEX_B><LOT_NUMBER>1</LOT_NUMBER><LOT_TITLE>Bleomycinum Sulfas</LOT_TITLE><LOT_DESCRIPTION><P>Bleomycinum Sulfas pulbere pt. solutie injectabila 15 000 ui.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 240, Cant. max. = 960; CS: Cant. min. = 15, Cant. max. = 60.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="10567.20">10 567,20</LOW_VALUE><HIGH_VALUE FMTVAL="42268.80">42 268,80</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 2 641,80 RON. Valoarea garantiei de participare este: 52,84 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>2</LOT_NUMBER><LOT_TITLE>Doxorubicinum 10 mg</LOT_TITLE><LOT_DESCRIPTION><P>Doxorubicinum 10 mg concentrat pt. solutie perfuzabila 10 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 480, Cant. max. = 1 920; CS: Cant. min. = 30, Cant. max. = 120.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="3907.20">3 907,20</LOW_VALUE><HIGH_VALUE FMTVAL="15628.80">15 628,80</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 976,80 RON. Valoarea garantiei de participare este: 19,54 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>3</LOT_NUMBER><LOT_TITLE>Doxorubicinum 20 mg</LOT_TITLE><LOT_DESCRIPTION><P>Doxorubicinum 20 mg concentrat pt. solutie perfuzabila 20 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 720, Cant. max. = 2 880; CS: Cant. min. = 45, Cant. max. = 180.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="12931.20">12 931,20</LOW_VALUE><HIGH_VALUE FMTVAL="51724.80">51 724,80</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 3 232,80 RON. Valoarea garantiei de participare este: 64,66 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>4</LOT_NUMBER><LOT_TITLE>Doxorubicinum 50 mg</LOT_TITLE><LOT_DESCRIPTION><P>Doxorubicinum 50 mg concentrat pt. solutie perfuzabila 50 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 720, Cant. max. = 2 880; CS: Cant. min. = 45, Cant. max. = 180.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="31024.80">31 024,80</LOW_VALUE><HIGH_VALUE FMTVAL="124099.20">124 099,20</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 7 756,20 RON. Valoarea garantiei de participare este: 155,12 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>5</LOT_NUMBER><LOT_TITLE>Topotecanum 4 mg</LOT_TITLE><LOT_DESCRIPTION><P>Topotecanum 4 mg pulbere sau concentrat pt. solutie perfuzabila 4 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 480, Cant. max. = 1 920; CS: Cant. min. = 30, Cant. max. = 120.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="85056.00">85 056,00</LOW_VALUE><HIGH_VALUE FMTVAL="340224.00">340 224,00</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 21 264 RON. Valoarea garantiei de participare este: 425,28 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>6</LOT_NUMBER><LOT_TITLE>Nivolumabum 40 mg</LOT_TITLE><LOT_DESCRIPTION><P>Nivolumabum 40 mg concentrat pt. solutie perfuzabila 40 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 48, Cant. max. = 480; CS: Cant. min. = 3, Cant. max. = 30.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="122371.20">122 371,20</LOW_VALUE><HIGH_VALUE FMTVAL="1223712.00">1 223 712,00</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 76 482 RON. Valoarea garantiei de participare este: 1 529,64 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>7</LOT_NUMBER><LOT_TITLE>Nivolumabum 100 mg</LOT_TITLE><LOT_DESCRIPTION><P>Nivolumabum 100 mg concentrat pt. solutie perfuzabila 100 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 48, Cant. max. = 480; CS: Cant. min. = 3, Cant. max. = 30.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="303768.00">303 768,00</LOW_VALUE><HIGH_VALUE FMTVAL="3037680.00">3 037 680,00</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 189 855 RON. Valoarea garantiei de participare este: 3 797,10 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>8</LOT_NUMBER><LOT_TITLE>Trastuzumabum Emtasinum 100 mg</LOT_TITLE><LOT_DESCRIPTION><P>Trastuzumabum Emtasinum 100 mg pulbere concentrat pt. solutie perfuzabila 100 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 48, Cant. max. = 480; CS: Cant. min. = 3, Cant. max. = 30.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="330750.24">330 750,24</LOW_VALUE><HIGH_VALUE FMTVAL="3307502.40">3 307 502,40</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 206 718,90 RON. Valoarea garantiei de participare este: 4 134,38 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>9</LOT_NUMBER><LOT_TITLE>Trastuzumabum Emtasinum 160 mg</LOT_TITLE><LOT_DESCRIPTION><P>Trastuzumabum Emtasinum 160 mg pulbere concentrat pt. solutie perfuzabila 60 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 48, Cant. max. = 480; CS: Cant. min. = 3, Cant. max. = 30.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="528336.48">528 336,48</LOW_VALUE><HIGH_VALUE FMTVAL="5283364.80">5 283 364,80</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 330 210.30 RON. Valoarea garantiei de participare este: 6 604,21 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B><F02_ANNEX_B><LOT_NUMBER>10</LOT_NUMBER><LOT_TITLE>Bevacizumabum 400 mg</LOT_TITLE><LOT_DESCRIPTION><P>Bevacizumabum 400 mg concentrat pt. solutie perfuzabila  400 mg.</P></LOT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN></CPV><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>AC: Cant. min. = 48, Cant. max. = 480; CS: Cant. min. = 3, Cant. max. = 30.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="209901.60">209 901,60</LOW_VALUE><HIGH_VALUE FMTVAL="2099016.00">2 099 016,00</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING><ADDITIONAL_INFORMATION_ABOUT_LOTS><P>Valoarea celui mai mare contract subsecvent: 131 188,50 RON. Valoarea garantiei de participare este: 2 623,77 RON.</P></ADDITIONAL_INFORMATION_ABOUT_LOTS></F02_ANNEX_B></F02_DIV_INTO_LOT_YES></F02_DIVISION_INTO_LOTS><ACCEPTED_VARIANTS VALUE="NO"/></DESCRIPTION_CONTRACT_INFORMATION><QUANTITY_SCOPE><NATURE_QUANTITY_SCOPE><TOTAL_QUANTITY_OR_SCOPE><P>Cantitatile sunt descrise in caietul de sarcini si in Anexa B.</P></TOTAL_QUANTITY_OR_SCOPE><COSTS_RANGE_AND_CURRENCY CURRENCY="RON"><RANGE_VALUE_COST><LOW_VALUE FMTVAL="1638613.92">1 638 613,92</LOW_VALUE><HIGH_VALUE FMTVAL="15525220.80">15 525 220,80</HIGH_VALUE></RANGE_VALUE_COST></COSTS_RANGE_AND_CURRENCY></NATURE_QUANTITY_SCOPE><NO_OPTIONS/></QUANTITY_SCOPE><PERIOD_WORK_DATE_STARTING><MONTHS>48</MONTHS></PERIOD_WORK_DATE_STARTING></OBJECT_CONTRACT_INFORMATION><LEFTI_CONTRACT><CONTRACT_RELATING_CONDITIONS><DEPOSITS_GUARANTEES_REQUIRED><P>Conform CS si Anexei B din fisa de date.</P><P>Perioada de valabilitate a GP: minim 120 de zile de la termenul limita de depunere a ofertelor. În cazul extinderii perioadei de valabilitate a ofertei, perioada de valabilitate a GP va fi prelungita în mod corespunzator, altfel se considera ca ofertantul si-a retras oferta.</P><P>Mod de constituire:</P><P>(a) depunere la casieria AC,</P><P>(b) virament bancar,</P><P>(c) instrument de garantare emis în conditiile legii de o societate bancara sau de o societate de asigurari.</P><P>In cazul scrisorii de garantie bancara se va folosi (Formular 1). Pentru toate formele de constituire a GP. Dovada garantiei de participare sa fie semnata obligatoriu cu semnatura electronica extinsa a semnatarului. Dovada constituirii GP se va prezenta în limba româna.</P><P>Neconstituirea GP pâna la data limita de depunere a ofertelor atrage respingerea ofertei. GP este irevocabila. Contul de garantie: RO71TREZ3515006XXX004081 deschis la Trezoreria Miercurea Ciuc. CF 4245305. Pt. conversia val. GP constituita intr-o alta moneda se va folosi cursul BNR din data publicarii anuntului de participare in SEAP.</P></DEPOSITS_GUARANTEES_REQUIRED><MAIN_FINANCING_CONDITIONS><P>Fonduri bugetare, fonduri Casa Nationala a Asigurarilor de Sanatate, fonduri Ministerul Sanatatii Programul National de Sanatate, venituri proprii.</P></MAIN_FINANCING_CONDITIONS><LEGAL_FORM><P>— Asociere conform art. 53 din Legea privind achizitiile publice nr. 98/2016,</P><P>— Asociere conform art. 66 din Legea privind achizitiile sectoriale nr. 99/2016,</P><P>— Asociere conform art. 39 din Legea privind concesiunile de lucrari si concesiunile de servicii nr. 100/2016.</P></LEGAL_FORM><NO_EXISTENCE_OTHER_PARTICULAR_CONDITIONS/></CONTRACT_RELATING_CONDITIONS><F02_CONDITIONS_FOR_PARTICIPATION><ECONOMIC_OPERATORS_PERSONAL_SITUATION><P>Cerinta 1: Ofertantii, tertii sustinatori si subcontractantii nu trebuie sa se regaseasca in situatiile prevazute la art. 59, 60, 164, 165, 167 din Legea nr. 98/2016.</P><P>Modalitatea prin care poate fi demonstrata indeplinirea cerintei: se va completa DUAE. Documentele justificative care probeaza îndeplinirea cerintelor asumate prin DUAE urmeza a fi prezentate la solicitarea autoritatii contractante doar de catre ofertantii clasati pe primele 5 locuri în clasamentul intermediar întocmit la finalizarea evaluarii ofertelor.</P><P>Aceste documente pot fi:</P><P>(a) certificate constatatoare privind lipsa datoriilor cu privire la plata impozitelor, taxelor sau a contributiilor la bugetul general consolidate (buget local, bucet de stat) restante la momentul prezentarii,</P><P>(b) cazier judiciar al operatorului economic si al membrilor organului de administrare, de conducere sau de supraveghere al respectivului operator economic, sau a celor ce au putere de reprezentare, de decizie sau de control in cadrul acestuia, asa cum rezulta din certificatul constatator emis de ONRC/actul constitutiv,</P><P>(c) dupa caz, documente prin care se demonstreaza faptul ca operatorul economic poate beneficia de derogarile prevazute la art. 166 alin. (2), art. 171 din Legea 98/2016 privind achizitiile publice.</P><P>Cerinta 2: Ofertantii/asociatii/tertii sustinatori nu trebuie sa se regaseasca in situatiile prevazute la art. 60 din Legea 98/2016. Persoanele cu functie de decizie din cadrul autoritatii contractante, in ceea ce priveste organizarea, derularea si finalizarea procedurii de atribuire, sunt:</P><P>— Dr. Konrád Judit – manager interimar,</P><P>— Dr. Kacso Jolan – director medical interimar,</P><P>— ec. Fülöp Eniko – director financiar contabil,</P><P>— as. pr. Vízi Mária-Melinda – director îngrijiri,</P><P>— jr. Márton Judit – consilier juridic,</P><P>— jr. Kovács Beáta – consilier juridic,</P><P>— ec. Ambrus Elod – sef Serviciu contabilitate,</P><P>— Opra Ana – contabil,</P><P>— Stekbauer Zsombor Norbert – economist Sef</P><P>— Serviciul Achizitii Publice, Császár Erika – economist,</P><P>— Serviciu Achizitii Publice, Lakatos Márta – informatician,</P><P>— Biró Mária – referent,</P><P>— Katona János – referent de specialitate,</P><P>— Molnár Ildikó – referent de specialitate,</P><P>— Szabó Jolán – referent,</P><P>— Veres Sarolta – farmacist principal,</P><P>— Szabó Anita-Krisztina – farmacist general,</P><P>— Nagy Mihai – registrator,</P><P>— András Edith – as. princ. de farmacie,</P><P>— Vén Rozália – as. de farmacie,</P><P>— Szocs Laura-Hermina – as. princ. de farmacie,</P><P>— Forika Imelda – as. princ. de farmacie,</P><P>— Darvas Ildikó – as. princ. de farmacie,</P><P>— Udvari Annamária – as. princ. de farmacie,</P><P>— Voda Elena – as. princ. de farmacie.</P><P>Modalitatea prin care poate fi demonstrata indeplinirea cerintei:</P><P>(a) Ofertantii vor completa cu informatiile aferente situatiei lor fisierul DUAE, publicat de autoritatea contractanta in cadrul Documentatiei de atribuire (prin intermediul adresei: https://ec.europa.eu/growth/toolsdatabases/espd/filter), dupa care il vor depune in SEAP – semnat, stampilat, scanat in format .pdf cu semnatura electronica.</P><P>Cerinta 3: Operatorii economici ce depun oferta, trebuie sa dovedeasca forma de înregistrare în conditiile legii din tara de rezidenta din care sa reiasa ca operatorul economic este legal constituit, ca nu se afla în niciuna dintre situatiile de anulare a constituirii, precum si faptul ca are capacitatea profesionala de a realiza activitatile care fac obiectul contractului.</P><P>Modalitate prin care pot fi demonstrate îndeplinirea cerintei:</P><P>(a) se va completa DUAE de catre operatorii economici participanti la procedura de atribuire cu informatiile aferente situatiei lor,</P><P>(b) documentele justificative care probeaza îndeplinirea cerintelor asumate prin DUAE, respectiv certificat constatator emis de ONRC sau în cazul ofertantilor straini documentele echivalente emise în tara de rezidenta, urmeza sa fie prezentate la solicitarea autoritatii contractante doar de catre ofertantii clasati pe primele 5 locuri în clasamentul intermediar întocmit la finalizarea evaluarii ofertelor. Informatiile din certificatul constatator trebuie sa fie  reale/valide la data prezentarii acestuia.</P><P>Cerinta 4: Ofertantii trebuie sa faca dovada ca sunt autorizati sa distribuie angro medicamente, conform prevederilor legale (Legea 95/2006 privind reforma în domeniul sanatatii republicata cu modificarile si completarile ulterioare – Capitolul IV: Fabricatie si import – art. 755 alin. (1) si alin. (3); art. 771 alin. (1)).</P><P>Modalitatea prin care poate fi demonstrata indeplinirea cerintei:</P><P>(a) Ofertantii vor completa cu informatiile aferente situatiei lor fisierul DUAE, publicat de autoritatea contractanta in cadrul documentatiei de atribuire (prin intermediul adresei: https://ec.europa.eu/growth/toolsdatabases/espd/filter), dupa care il vor depune in SEAP – semnat, stampilat, scanat in format .pdf cu semnatura electronica,</P><P>(b) Documentele justificative care vor proba îndeplinirea celor asumate prin completarea DUAE vor fi prezentate la solicitarea autoritatii contractante, doar de catre ofertantii clasati pe primele 5 locuri. Aceste documente sunt: autorizatia de distributie angro a medicamentelor eliberat de Agentia Nationala a Medicamentului – scanat in format .pdf si semnat electronic.</P><P>Cerinta 5: Ofertantii trebuie sa faca dovada ca sunt autorizati sa puna pe piata produsele ofertate, conform prevederilor legale (Legea 95/2006 privind reforma în domeniul sanatatii republicata cu modificarile si completarile ulterioare – Capitolul III: Punerea pe piata – Sectiunea 1: Autorizarea de punere pe piata – art. 704 alin. (1) si Ordinul nr. 761 din 17 iunie 2015 pentru aprobarea Ghidului privind buna practica de distributie angro a medicamentelor – Capitolul VI: Operatiuni – Sectiunea 1: Principii – art. 21 alin. (2)).</P><P>Modalitatea prin care poate fi demonstrata indeplinirea cerintei:</P><P>(a) Ofertantii vor completa cu informatiile aferente situatiei lor fisierul DUAE, publicat de autoritatea contractanta in cadrul documentatiei de atribuire (prin intermediul adresei: https://ec.europa.eu/growth/toolsdatabases/espd/filter), dupa care il vor depune in SEAP – semnat, stampilat, scanat in format .pdf cu semnatura electronica,</P><P>(b) Documentele justificative care vor proba îndeplinirea celor asumate prin completarea DUAE vor fi prezentate la solicitarea autoritatii contractante, doar de catre ofertantii clasati pe primele 5 locuri. Aceste documente sunt: autorizatia de punere pe piata eliberat de Agentia Nationala a Medicamentului – scanat in format .pdf si semnat electronic.</P><P>În cazul operatorilor economici straini, se vor prezenta documente echivalente emise în conformitate cu legislatia aplicabila în tara de rezidenta, urmând sa fie prezentat la solicitarea autoritatii contractante doar la catre ofertantul clasat pe locul I–V în clasamentul intermediar întocmit la finalizarea evaluarii ofertelor.</P></ECONOMIC_OPERATORS_PERSONAL_SITUATION></F02_CONDITIONS_FOR_PARTICIPATION><SERVICES_CONTRACTS_SPECIFIC_CONDITIONS><NO_EXEC_SERVICE_RESERVED_PARTICULAR_PROFESSION/><REQUESTS_NAMES_PROFESSIONAL_QUALIFICATIONS VALUE="NO"/></SERVICES_CONTRACTS_SPECIFIC_CONDITIONS></LEFTI_CONTRACT><PROCEDURE_DEFINITION_CONTRACT_NOTICE><TYPE_OF_PROCEDURE><TYPE_OF_PROCEDURE_DETAIL_FOR_CONTRACT_NOTICE><PT_OPEN/></TYPE_OF_PROCEDURE_DETAIL_FOR_CONTRACT_NOTICE></TYPE_OF_PROCEDURE><AWARD_CRITERIA_CONTRACT_NOTICE_INFORMATION><AWARD_CRITERIA_DETAIL><LOWEST_PRICE/></AWARD_CRITERIA_DETAIL><IS_ELECTRONIC_AUCTION_USABLE><NO_USE_ELECTRONIC_AUCTION/></IS_ELECTRONIC_AUCTION_USABLE></AWARD_CRITERIA_CONTRACT_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_NOTICE><FILE_REFERENCE_NUMBER><P>10300/20.10.2017</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F2><NO_PREVIOUS_PUBLICATION_EXISTS_F2/></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F2><CONDITIONS_OBTAINING_SPECIFICATIONS><TIME_LIMIT><DAY>04</DAY><MONTH>05</MONTH><YEAR>2018</YEAR><TIME>15:00</TIME></TIME_LIMIT><NO_PAYABLE_DOCUMENTS/></CONDITIONS_OBTAINING_SPECIFICATIONS><RECEIPT_LIMIT_DATE><DAY>15</DAY><MONTH>05</MONTH><YEAR>2018</YEAR><TIME>16:00</TIME></RECEIPT_LIMIT_DATE><LANGUAGE><LANGUAGE_EC VALUE="RO"/></LANGUAGE><MINIMUM_TIME_MAINTAINING_TENDER><PERIOD_DAY>120</PERIOD_DAY></MINIMUM_TIME_MAINTAINING_TENDER><CONDITIONS_FOR_OPENING_TENDERS><DATE_TIME><DAY>08</DAY><MONTH>06</MONTH><YEAR>2018</YEAR><TIME>18:00</TIME></DATE_TIME><PLACE_OPENING><PLACE_NOT_STRUCTURED><P>In SEAP.</P></PLACE_NOT_STRUCTURED></PLACE_OPENING><NO_EXISTENCE_AUTHORISED_PERSONS/></CONDITIONS_FOR_OPENING_TENDERS></ADMINISTRATIVE_INFORMATION_CONTRACT_NOTICE></PROCEDURE_DEFINITION_CONTRACT_NOTICE><COMPLEMENTARY_INFORMATION_CONTRACT_NOTICE><NO_RECURRENT_PROCUREMENT/><RELATES_TO_EU_PROJECT_NO/><ADDITIONAL_INFORMATION><P>Modul de departajare a ofertelor cu preturi egale: pentru fiecare lot in parte:</P><P>In cazul ofertelor cu preturi egale (doua sau mai multe oferte) si clasate pe acelasi loc, modul de departajare intre oferte se va face prin reofertarea preturilor. Pretul reofertat nu poate fi îmbunatatit decât pâna la nivelul pretului ofertat de operatorul clasat pe locul anterior.</P><P>In cazul in care comisia de evaluare constata ca au fost depuse oferte admisibile cu preturi unitare egale la ofertantii clasati pe primul loc, autoritatea contractanta va solicita reofertarea preturilor, caz in care contractul va fi atribuit ofertantului al carui noua propunere financiara are pretul cel mai scazut.</P><P>In cazul reofertarii pretul unitar poate fi ofertat cu trei zecimale tinandu-se cont de impachetare, astfel incat pretul pe cutie sa fie cu doua zecimale.</P><P>In cazul in care dupa reofertare, pentru ofertele clasate pe primul loc preturile unitare sunt egale, autoritatea contractanta va respinge ofertele respective ca inacceptabile, devenind astfel castigatoare oferta clasata pe urmatorul loc, sau in cazul in care nu exista alta oferta admisibila va anula lotul respectiv.</P><P>Acordul-cadru se reziliaza pe deplin drept in eventualitatea realizarii licitatiei în conformitate cu OUG 71/2012, efectuat de Ministerul Sanatatii la nivel national.</P></ADDITIONAL_INFORMATION><PROCEDURES_FOR_APPEAL><APPEAL_PROCEDURE_BODY_RESPONSIBLE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Consiliul Național de Soluționare a Contestațiilor</OFFICIALNAME></ORGANISATION><ADDRESS>Str. Stavropoleos nr. 6, sector 3</ADDRESS><TOWN>București</TOWN><POSTAL_CODE>030084</POSTAL_CODE><COUNTRY VALUE="RO"/><E_MAILS><E_MAIL>office@cnsc.ro</E_MAIL></E_MAILS><PHONE>+40 213104641</PHONE><URL>http://www.cnsc.ro</URL><FAX>+40 213104642 / +40 218900745</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></APPEAL_PROCEDURE_BODY_RESPONSIBLE><LODGING_INFORMATION_FOR_SERVICE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Compartimentul Juridic al Spitalului Județean de Urgență Miercurea Ciuc</OFFICIALNAME></ORGANISATION><ADDRESS>Str. Miko nr. 1</ADDRESS><TOWN>Miercurea Ciuc</TOWN><POSTAL_CODE>530180</POSTAL_CODE><COUNTRY VALUE="RO"/><E_MAILS><E_MAIL>secretariat@spitalmciuc.ro</E_MAIL></E_MAILS><PHONE>+40 266324193</PHONE><FAX>+40 266372137</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></LODGING_INFORMATION_FOR_SERVICE></PROCEDURES_FOR_APPEAL><NOTICE_DISPATCH_DATE><DAY>04</DAY><MONTH>04</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_NOTICE></FD_CONTRACT></CONTRACT></FORM_SECTION></TED_EXPORT>